Earnings Feed
Start Free
Home/Filings/3/0000950170-25-075947
3//SEC Filing

11.2 Capital I, L.P. 3

Accession 0000950170-25-075947

CIK 0001673743other
View on SEC.govCompany Profile

Filed

May 20, 8:00 PM ET

Accepted

May 21, 6:52 PM ET

Size

18.7 KB

Accession

0000950170-25-075947

Insider Transaction Report

Form 3
Period: 2025-05-21
Hinge Health, Inc.HNGE
11.2 Capital I, L.P.
10% Owner
Holdings

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,932,367 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,230,364 underlying)

  • Series A-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (230,923 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (251,606 underlying)

  • Series S-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,455,604 underlying)
11.2 Capital Ivy Partners, LLC
10% Owner
Holdings

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,230,364 underlying)

  • Series A-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (230,923 underlying)

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,932,367 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (251,606 underlying)

  • Series S-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,455,604 underlying)
Zhuang Qian
10% Owner
Holdings

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,932,367 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (251,606 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,230,364 underlying)

  • Series A-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (230,923 underlying)

  • Series S-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,455,604 underlying)
11.2 Capital HH, LLC
10% Owner
Holdings

  • Series S-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,455,604 underlying)

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,932,367 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,230,364 underlying)

  • Series A-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (230,923 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (251,606 underlying)
11.2 Capital Ivy, LLC
10% Owner
Holdings

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,932,367 underlying)

  • Series A-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (230,923 underlying)

  • Series S-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,455,604 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,230,364 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (251,606 underlying)
11.2 Capital I Partners, LLC
10% Owner
Holdings

  • Series S-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,455,604 underlying)

  • Series A-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (230,923 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,230,364 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (251,606 underlying)

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,932,367 underlying)
Footnotes (5)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, will automatically convert and be reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
  • [F2]11.2 Capital I Partners, LLC is the general partner of 11.2 Capital I, L.P. ("11.2 Capital I") and 11.2 Capital Ivy Partners, LLC is the general partner of each of 11.2 Capital HH, LLC ("11.2 Capital HH") and 11.2 Capital IVY, LLC ("11.2 Capital IVY" and together with 11.2 Capital HH and 11.2 Capital I, the "11.2 Capital Entities")). Shelley Zhuang is the sole managing member of each of 11.2 Capital I Partners, LLC and 11.2 Capital Ivy Partners, LLC. As a result, each of the foregoing may be deemed to share beneficial ownership of the securities held by the 11.2 Capital Entities.
  • [F3]Securities held of record by 11.2 Capital I.
  • [F4]Consists of (i) 205,060 shares held by 11.2 Capital I and (ii) 1,025,304 shares held by 11.2 Capital IVY.
  • [F5]Consists of (i) 171,550 shares held by 11.2 Capital HH and (ii) 80,056 shares held by 11.2 Capital IVY.

Documents

1 file

Issuer

Hinge Health, Inc.

CIK 0001673743

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001591336

Filing Metadata

Form type
3
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:52 PM ET
Size
18.7 KB
View on SEC.gov